These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2941487)

  • 1. Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patients.
    Moody DJ; Fahey JL; Durkos-Smith D; Ellison GW; Myers LW
    J Immunopharmacol; 1986; 8(2):259-69. PubMed ID: 2941487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
    Merrill JE
    J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    J Clin Immunol; 1984 Jul; 4(4):312-8. PubMed ID: 6378956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
    Hattori T; Hirata F; Hoffman T; Hizuta A; Herberman RB
    J Immunol; 1983 Aug; 131(2):662-5. PubMed ID: 6223089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
    Fukui H; Overton WR; Herberman RB; Reynolds CW
    J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locus of selective depression of human natural killer cells by azathioprine.
    Shih WW; Ellison GW; Myers LW; Durkos-Smith D; Fahey JL
    Clin Immunol Immunopathol; 1982 Jun; 23(3):672-81. PubMed ID: 6180857
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibition of natural killer (NK) and antibody-dependent cell-mediated cytoxicity (ADCC) activities.
    Floyd RA; Kuo CY; Yoo TJ; Song A; Postlethwaite AE; Mainardi C
    J Lab Clin Med; 1984 Feb; 103(2):215-22. PubMed ID: 6693794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
    Cooley S; Burns LJ; Repka T; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of killer cell cytotoxicity induced by carbimazole in vitro.
    Pozzilli P; Sensi M; Andreani D
    J Endocrinol Invest; 1982; 5(3):149-52. PubMed ID: 7108149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
    Lieberman MD; Sigal RK; Williams NN; Daly JM
    J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVIG induces apoptotic cell death in CD56
    Bunk S; Ponnuswamy P; Trbic A; Malisauskas M; Anderle H; Weber A; Ilas J; Winkler AM; Butterweck HA; Teschner W; Scheiflinger F; Hermann C; Reipert BM
    Clin Immunol; 2019 Jan; 198():62-70. PubMed ID: 30389480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of monthly pulses of cyclophosphamide in multiple sclerosis patients. Delayed recovery of several immune parameters following discontinuation of long-term cyclophosphamide treatment.
    Moody DJ; Fahey JL; Grable E; Ellison GW; Myers LW
    J Neuroimmunol; 1987 Mar; 14(2):175-82. PubMed ID: 2950131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.